{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,18]],"date-time":"2025-10-18T20:29:16Z","timestamp":1760819356476},"reference-count":31,"publisher":"Wiley","issue":"3","license":[{"start":{"date-parts":[[2008,10,9]],"date-time":"2008-10-09T00:00:00Z","timestamp":1223510400000},"content-version":"vor","delay-in-days":3691,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clinical Endocrinology"],"published-print":{"date-parts":[[1998,9]]},"abstract":"<jats:sec><jats:title>OBJECTIVE<\/jats:title><jats:p>Premature ovarian failure is associated with a reduction in bone mineral density. As survival rates following treatment for haematological malignancies improve, chemotherapy\u2010induced ovarian failure is becoming more common. However, there are few data concerning the impact of this on bone mineral density (BMD). We have therefore measured the BMD in 33 women with ovarian failure following treatment with cytotoxic chemotherapy.<\/jats:p><\/jats:sec><jats:sec><jats:title>PATIENTS AND DESIGN<\/jats:title><jats:p>We studied 33 women who received combination chemotherapy for Hodgkin's disease (<jats:italic>n<\/jats:italic>\u2003=\u200327), non\u2010Hodgkin's lymphoma (<jats:italic>n<\/jats:italic>=\u20034), sarcoma (<jats:italic>n<\/jats:italic>\u2003=\u20031) and acute myeloid leukaemia (<jats:italic>n<\/jats:italic>=\u20031). The mean (range) age of the subjects at the time of BMD measurement was 37.5 (24\u201350) years and the mean (median: range) duration of amenorrhoea was 49 (24: 5\u2013277) months. Eleven women had received hormone replacement therapy (HRT) for a mean (range) duration of 25 (1\u201362) months. BMD was measured by single photon absorptiometry or single X\u2010ray absorptiometry, and dual energy X\u2010ray absorptiometry at the distal and proximal radius, the femoral neck and the lumbar spine, respectively. BMD was expressed as <jats:italic>Z<\/jats:italic>\u2010scores and statistical analysis was performed using the Wilcoxon matched\u2010pairs signed\u2010rank test.<\/jats:p><\/jats:sec><jats:sec><jats:title>RESULTS<\/jats:title><jats:p>There was no significant reduction in BMD at the hip, spine or forearm in the cohort as a whole, although there was a trend to reduce bone density at all sites. When patients who had received HRT were excluded from the analysis there were small reductions in mean BMD at all sites, but this was only statistically significant at the proximal forearm (<jats:italic>Z<\/jats:italic>\u2010score\u2003=\u2003\u22120.65; <jats:italic>P<\/jats:italic>\u2003=\u20030.03). Mean BMD of the HRT\u2010treated patients was normal at all sites. Only seven patients (21%) had a BMD <jats:italic>Z<\/jats:italic>\u2010score\u2003&lt;\u2003\u22122 at any site.<\/jats:p><\/jats:sec><jats:sec><jats:title>CONCLUSION<\/jats:title><jats:p>It is inappropriate to assume that ovarian failure from different aetiologies has a similar deleterious impact on the skeleton. Untreated premature ovarian failure following cytotoxic chemotherapy results in some reduction in bone mineral density, but this is of a minor degree and is less than that observed in other hypo\u2010oestrogenic states. The reason for this is unclear but studies of residual hormone production in the cytotoxic\u2010damaged ovary may provide an answer.<\/jats:p><\/jats:sec>","DOI":"10.1046\/j.1365-2265.1998.00550.x","type":"journal-article","created":{"date-parts":[[2003,3,11]],"date-time":"2003-03-11T10:38:26Z","timestamp":1047379106000},"page":"397-402","source":"Crossref","is-referenced-by-count":15,"title":["Bone mineral density in women with cytotoxic\u2010induced ovarian failure"],"prefix":"10.1111","volume":"49","author":[{"family":"Howell","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"family":"Berger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"family":"Adams","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"family":"Shalet","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2008,10,9]]},"reference":[{"key":"e_1_2_5_2_2","first-page":"247","article-title":"Hormone replacement therapy increases trabecular and cortical bone density in osteoporotic women","volume":"56","author":"Bagur D.","year":"1996","journal-title":"Medicina Buenas Aires"},{"key":"e_1_2_5_3_2","doi-asserted-by":"publisher","DOI":"10.1038\/bjc.1990.58"},{"key":"e_1_2_5_4_2","doi-asserted-by":"publisher","DOI":"10.1016\/0378-5122(95)00991-4"},{"key":"e_1_2_5_5_2","doi-asserted-by":"crossref","first-page":"1877","DOI":"10.1001\/jama.1979.03300170023020","article-title":"Cytotoxic\u2010induced ovarian failure in women with Hodgkin's disease. I. Hormone function","volume":"242","author":"Chapman R.M.","year":"1979","journal-title":"Journal of the American Medical Association"},{"key":"e_1_2_5_6_2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.1995.13.1.134"},{"key":"e_1_2_5_7_2","doi-asserted-by":"publisher","DOI":"10.1016\/0140-6736(93)92555-8"},{"key":"e_1_2_5_8_2","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.301.6755.790"},{"key":"e_1_2_5_9_2","doi-asserted-by":"publisher","DOI":"10.1016\/0378-5122(94)00898-H"},{"key":"e_1_2_5_10_2","doi-asserted-by":"publisher","DOI":"10.1259\/0007-1285-41-485-362"},{"key":"e_1_2_5_11_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM198408023110501"},{"key":"e_1_2_5_12_2","doi-asserted-by":"publisher","DOI":"10.1016\/0028-2243(91)90088-3"},{"key":"e_1_2_5_13_2","doi-asserted-by":"publisher","DOI":"10.1148\/radiology.161.3.3786724"},{"key":"e_1_2_5_14_2","doi-asserted-by":"publisher","DOI":"10.1016\/0378-5122(95)00940-M"},{"key":"e_1_2_5_15_2","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/3.suppl_4.S105"},{"key":"e_1_2_5_16_2","doi-asserted-by":"publisher","DOI":"10.1042\/cs0620329"},{"key":"e_1_2_5_17_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF01622256"},{"key":"e_1_2_5_18_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF01622262"},{"key":"e_1_2_5_19_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0015-0282(16)60846-4"},{"key":"e_1_2_5_20_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0015-0282(16)54773-6"},{"key":"e_1_2_5_21_2","doi-asserted-by":"publisher","DOI":"10.1210\/jcem-65-4-697"},{"key":"e_1_2_5_22_2","doi-asserted-by":"publisher","DOI":"10.1002\/hon.2900100308"},{"key":"e_1_2_5_23_2","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9343(88)90504-9"},{"key":"e_1_2_5_24_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM198411153112002"},{"key":"e_1_2_5_25_2","doi-asserted-by":"publisher","DOI":"10.1210\/jc.81.12.4453"},{"key":"e_1_2_5_26_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1471-0528.1992.tb13879.x"},{"key":"e_1_2_5_27_2","doi-asserted-by":"publisher","DOI":"10.1210\/jc.75.3.698"},{"key":"e_1_2_5_28_2","doi-asserted-by":"publisher","DOI":"10.1172\/JCI118382"},{"key":"e_1_2_5_29_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF01623185"},{"key":"e_1_2_5_30_2","doi-asserted-by":"publisher","DOI":"10.1530\/eje.0.1320047"},{"key":"e_1_2_5_31_2","unstructured":"World Health Organization(1994)Assessment of Fracture Risk and its Application to Screening for Postmenopausal Osteoporosis. Technical report series 843. World Health Organisation Geneva."},{"key":"e_1_2_5_32_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0020-7292(96)02756-7"}],"container-title":["Clinical Endocrinology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1046%2Fj.1365-2265.1998.00550.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1046%2Fj.1365-2265.1998.00550.x","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1046\/j.1365-2265.1998.00550.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,16]],"date-time":"2023-10-16T02:42:36Z","timestamp":1697424156000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1046\/j.1365-2265.1998.00550.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1998,9]]},"references-count":31,"journal-issue":{"issue":"3","published-print":{"date-parts":[[1998,9]]}},"alternative-id":["10.1046\/j.1365-2265.1998.00550.x"],"URL":"https:\/\/doi.org\/10.1046\/j.1365-2265.1998.00550.x","archive":["Portico"],"relation":{},"ISSN":["0300-0664","1365-2265"],"issn-type":[{"value":"0300-0664","type":"print"},{"value":"1365-2265","type":"electronic"}],"subject":[],"published":{"date-parts":[[1998,9]]}}}